InvestorsHub Logo
Followers 14
Posts 610
Boards Moderated 0
Alias Born 04/27/2010

Re: WallStBull post# 551

Saturday, 11/09/2013 12:56:18 PM

Saturday, November 09, 2013 12:56:18 PM

Post# of 6624
NOTICE OF EXTRAORDINARY GENERAL MEETING OF ARCAM AB
Fri , November 8, 2013 02:30 ET

Shareholders of Arcam AB (publ) , corporate identity number 556539-5356 , are hereby invited to an Extraordinary General Meeting on Friday, December 6, 2013 at 16:00 , at the company's premises , Krokslätts Factories 27A , Mölndal. Registration for the meeting is between the hours of 15:30 to 16:00 .

Shareholders wishing to participate in the Meeting

be registered in their own name ( not nominee-registered ) in the Euroclear Sweden AB share register by 29 November 2013

notify the company not later than 4 December 2013 at 12:00 , at the address Arcam AB , Krokslätts Factories 27A , 431 37 Mölndal , or by fax at 031-710 32 01 , or via e-mail carolina@arcam.com .

The number of attending assistants (maximum two ) must be notified at the same time .

In the notification, the shareholder shall state personal or corporate , address and telephone number. Shareholders represented by proxy shall produce a written and dated power of attorney , as at the date of the AGM can not be older than five years. Proxy and representative of a legal person shall submit authorization documents prior to the meeting (signed and dated power of attorney and / or current registration certificate ) .

Shareholders with nominee- registered shares must temporarily re-register their shares in their own name to be entitled to attend the meeting . Such registration must be completed at Euroclear Sweden AB by 29 November 2013 and the nominee must be notified in advance of this date.

Draft Agenda

At an Extraordinary General Meeting , the following matters:

1. opening of the meeting

2nd Election of Chairman of the Meeting

3rd Preparation and approval of voting list

4. Selection of at least one minutes

5th Ask whether the Meeting has been duly convened

6. Adoption of the agenda

7. Decisions on stock split and amendment of the Articles of Association

8. Decision to authorize the Board to issue new shares , convertible debentures or debentures with warrants .

9. closing of the meeting

Motions

Decision on reduction of share ( "split " ) of shares and amendment of articles of association (item 7)

The Board of Directors proposes to the AGM in order to achieve the appropriate number of shares , to decide on the split of shares and adopt coherent change in the Articles of Association.

a) Split of shares

The Board proposes that the Meeting in order to achieve the appropriate number of shares , decide on a split of shares 4:1 , meaning that 1 (one) share is divided into 4 (four ) shares.

b) Amendment of the Articles of Association

In view of the above proposals for split of shares , the Board proposes that § 5 Number of shares, in the present Articles of Association be amended to the following wording

The number of shares shall be not less than 12,000,000 ( 3,000,000 ) and a maximum of 48,000,000 ( 12,000,000 ) .

Decision to authorize the Board to issue new shares , convertible debentures or debentures with warrants (item 8)

The Board proposes that the Meeting authorize the Board, until the next Annual General Meeting, on one or more occasions, to issue new shares, issue of convertible bonds or warrants. The issue shall be made ??with or without deviation from the shareholders ' preferential rights and with or without non-cash , offset, or other terms. The overall increase of the share capital pursuant to the authorization shall not exceed 1 600 000, representing an increase of share capital from the current 16 741 633,50 to a maximum of 18 341 633.50 , ie an increase by a maximum of just under 10%. The shares will be issued at the current market price .

This authorization is to give the Board flexibility in efforts to finance and facilitate accelerated expansion and development of the Company, its market and products.

other Information

Resolution to adopt the points 7 and 8 are valid only if supported by shareholders representing at least two thirds of the votes cast at the meeting at which the shares represented .

Total number of shares and votes in the Company is 4,185,408 at the time of issuing this notice. All shares are of the same kind.

Complete proposal , including background to item 7 will be available to shareholders at the Arcam AB's office , Krokslätts Factories 27A , 431 37 Mölndal, Sweden , and the company's website www.arcam.com , from by 8 November 2013 and will be mailed to the shareholders who so request and state their address.

Shareholders under Chapter 7, § 32 Companies Act ( 2005:551), the right to the Meeting request information from the Board and CEO of circumstances that may affect items on the agenda and circumstances which may affect the company 's financial situation.

Mölndal in November 2013

Arcam AB (publ)

Board of Directors

Arcam manufactures equipment directly from digital three-dimensional models produce components from metal powder , known as Additive Manufacturing. Arcam technology, EBM ® , allows for cost-effective production of products with advanced functionality. Arcam's market is global with customers primarily in orthopedic implants and aerospace industries . The company was founded in 1997 and is listed on NASDAQ OMX. Head office and production facilities are located in Mölndal. Service Center in the USA, UK, Italy and China.

________________________________________________________________________________________

Arcam AB • Krokslätts Factories 27A • SE- 431 37 Mölndal , Sweden • 46-31-710 32 00 • www.arcam.com


For further information please contact:
Magnus René , CEO of Arcam AB
Phone: 031 710 32 00 or . mobile: 0702 79 89 99 or E-mail: magnus.rene @ arcam.com
About Us

Arcam manufactures equipment directly from digital three-dimensional models produce components from metal powder , known as Additive Manufacturing. Arcam technology, EBM ® , allows for cost-effective production of products with advanced functionality. Arcam's market is global with customers primarily in orthopedic implants and aerospace industries . The company was founded in 1997 and is listed on NASDAQ OMX. Head office and production facilities are located in Mölndal. Service Center in the USA, Italy and China.
plug

Arcam
+46 31-710 32 00
info@arcam.com

Documents and Links

release

© Cision

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.